Africa Daily Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa Daily Journal.

Press releases published on May 20, 2026

Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
American Gold & Copper Inc. (OTC: EVLI) Featured in Executive Interview with Brent Nelson Highlighting Strategy Following Transformative Reverse Merger
Skyharbour Announces Commencement of Drilling at the RL Uranium Project, Saskatchewan
SONORO GOLD ANNOUNCES $10 MILLION PRIVATE PLACEMENT
IUX Publishes Market Insight on AI Momentum and U.S. Equity Markets
Dynacor Group Announces Changes to Board of Directors
Groupe Dynacor annonce des changements au sein de son conseil d’administration
4basebio Signs Clinical Supply Agreement to Support Phase II Clinical Trial
Final Results and Notice of AGM
Ichnos Glenmark Innovation (IGI) Announces New Development Candidate, ISB 2301, a First-in-Class Multispecific Immune Cells Activator Targeting Solid Tumors
Verde AgriTech Announces Formation of Magnes Rare Earths and Leadership Transition to Sharpen Focus and Unlock Value Across Two Distinct Growth Platforms
Lahontan Provides Santa Fe Mine Development and Permitting Update, Grants Stock Options
Aya Gold & Silver Reports High-Grade Exploration Drill Results at Boumadine
DPM Metals Reports New High-Grade Intercepts from the Chelopech Wedge Zone Deep Prospect; Expects Mineral Resource Estimate by Year-End 2026
Azimut Continues to Expand the Fortin Antimony-Gold Zone, Wabamisk Property, James Bay Region, Québec
Azimut poursuit l’expansion de la Zone Fortin (Antimoine-Or) Propriété Wabamisk, région de la Baie James, Québec
IUX Strengthens Asia Presence with Gold Sponsorship at Traders Fair Manila 2026
MEXC Launches SpaceX Pre-IPO Launchpad, Opening New 0-Fee Access Channel
SERB Pharmaceuticals erwirbt von Hansa Biopharma europäische und MENA-Rechte an Idefirix® (Imlifidase) für 115 Mio. €
SERB Pharmaceuticals acquiert auprès de Hansa Biopharma les droits européens et MENA d’Idefirix® (imlifidase) pour 115 millions d’euros

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Africa Daily Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.